| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA149: Carmustine implants for the treatment of recurrent glioblastoma multiforme (terminated appraisal). |
|
Medicine details |
|
| Medicine name | carmustine (Gliadel®) |
| Formulation | 7.7 mg implant |
| Reference number | 76 |
| Indication | Adjunct to surgery in patients with recurrent glioblastoma multiforme |
| Company | Archimedes Pharma UK Ltd |
| BNF chapter | Malignant disease & immunosuppression |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 01/05/2011 |
| NICE guidance | |